Catalyst

Slingshot members are tracking this event:

Sarepta Therapeutics Announces FDA Will Not Complete the Review of the Eteplirsen New Drug Application By The PDUFA Date

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SRPT Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 25, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Rna-targeted Therapeutics, Pdufa, Eteplirsen, Fda